$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Prosensa Holding NV
(NASDAQ : RNA)

( )
RNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading RNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.52%80.081.6%$971.03m
BIIBBiogen Inc.
-0.80%306.851.2%$601.61m
AMGNAmgen Inc.
-0.36%170.231.0%$513.92m
CELGCelgene Corporation
-2.43%107.910.8%$487.34m
MDVNMedivation, Inc.
0.01%80.241.8%$407.06m
REGNRegeneron Pharmaceuticals, Inc.
-1.23%400.253.4%$310.90m
ILMNIllumina, Inc.
-0.04%169.484.4%$237.64m
BMRNBioMarin Pharmaceutical Inc.
-0.17%94.973.6%$203.07m
ALXNAlexion Pharmaceuticals, Inc.
-2.23%129.172.6%$190.18m
VRTXVertex Pharmaceuticals Incorporated
-0.34%96.382.3%$119.34m
EXASExact Sciences Corporation
0.42%19.0530.9%$116.66m
INCYIncyte Corporation
-2.84%80.102.6%$100.75m
AAgilent Technologies, Inc.
1.18%47.250.9%$92.74m
IONSIonis Pharmaceuticals, Inc.
-4.01%30.3711.1%$91.84m
TSROTESARO, Inc.
-2.16%85.2315.8%$86.13m

Company Profile

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.